Mar 28, 2018
Top Pharma News of the Week – March 26th
Top Pharma News of the Week – March 26th
All The Most Important Pharmaceutical News Stories Of The Week – March 2018 – Week #4 Seattle Genetics Announces FDA Approval of ADCETRIS® (Brentuximab Vedotin) in Combination with Chemotherapy for Adults with Previously Untreated Stage III or IV Classical Hodgkin Lymphoma
March 20, 2018
Seattle Genetics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved ADCETRIS…
View On WordPress